Genetics
CETP TaqIB genotype raises HDL cholesterol but does not predict Alzheimer's disease risk in a Han Chinese cohort (Lipids Health Dis 2012)
Original title: Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease
In a case-control study of 208 Han Chinese from Changsha (104 Alzheimer's disease patients and 104 non-demented controls), researchers tested whether ABCA1 R219K, CETP TaqIB and LIPC -250 G/A polymorphisms were associated with Alzheimer's disease susceptibility and plasma lipid levels. After adjusting for other factors, only ABCA1 R219K (odds ratio 0.405, P equals 0.005) and LIPC -250 G/A (odds ratio 0.405, P equals 0.018) were independently associated with decreased Alzheimer's disease risk, while CETP TaqIB showed no association with disease risk despite being a significant determinant of HDL cholesterol, with the B2B2 genotype linked to significantly higher HDL cholesterol levels than other genotypes (P equals 0.004).
Original abstract
Objectives: Accumulating evidence suggested that dysregulation of cholesterol homeostasis might be a major etiologic factor in initiating and promoting neurodegeneration in Alzheimer's disease (AD). ATP-binding cassette transporter A1 (ABCA1), hepatic lipase (HL, coding genes named LIPC) and cholesteryl ester transfer protein (CETP) are important components of high-density lipoprotein (HDL) metabolism and reverse cholesterol transport (RCT) implicated in atherosclerosis and neurodegenerative diseases. In the present study, we will investigate the possible association of several common polymorphisms (ABCA1R219K, CETPTaqIB and LIPC-250 G/A) with susceptibility to AD and plasma lipid levels.
Methods: Case-control study of 208 Han Chinese (104 AD patients and 104 non-demented controls) from Changsha area in Hunan Province was performed using the PCR-RFLP analysis. Cognitive decline was assessed using Mini Mental State Examination (MMSE) as a standardized method. Additionally, fasting lipid profile and the cognitive testing scores including Wechsler Memory Scale (WMS) and Wisconsin Card Sorting Test (WCST) were recorded.
Results And Conclusions: We found significant differences among the genotype distributions of these three genes in AD patients when compared with controls. But after adjusting other factors, multivariate logistic regression analysis showed only ABCA1R219K (B=-0.903, P=0.005, OR=0.405, 95%CI:0.217-0.758) and LIPC-250 G/A variants(B=-0.905, P=0.018, OR=0.405, 95%CI:0.191-0.858) were associated with decreased AD risk. There were significantly higher levels of high-density lipoprotein cholesterol (HDL-C) and apolipoproteinA-I in the carriers of KK genotype and K allele (P < 0.05), and B2B2 genotype of CETP Taq1B showed significant association with higher HDL-C levels than other genotypes (F=5.598, P=0.004), while -250 G/A polymorphisms had no significant effect on HDL-C. In total population, subjects carrying ABCA1219K allele or LIPC-250A allele obtained higher MMSE or WMS scores than non-carriers, however, no significant association was observed in AD group or controls. Therefore, this preliminary study showed that the gene variants of ABCA1R219K and LIPC-250 G/A might influence AD susceptibility in South Chinese Han population, but the polymorphism of CETPTaq1B didn't show any association in despite of being a significant determinant of HDL-C.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.